<DOC>
	<DOC>NCT00525278</DOC>
	<brief_summary>To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis</brief_summary>
	<brief_title>To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Male or female, 18 to 60 years old, inclusive twoyear history of allergic rhinitis due to tree, grass or weed pollen sufficient histaminedependent symptoms of rhinitis during the selection week (T5SS ≥ 5) An ear, nose or throat (ENT) infection asthma requiring daily drug therapy other than ß2 inhaled agonists taken prn atopic dermatitis or urticaria requiring an antihistamine or corticosteroid treatment an associated ENT disease use of decongestants nasal or ocular topical treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levocetirizine dihydrochloride</keyword>
	<keyword>Xyzal tablets</keyword>
</DOC>